(Q45972467)

18 December 2017

title

Snake venom coagulopathy: use and abuse of blood products in the treatment of pit viper envenomation. (English)

1 reference

18 December 2017

blood coagulation disease

1 reference

0 references

1 reference

2

Dart RC

1 reference

18 December 2017

author name string

Burgess JL

series ordinal

1

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 July 1991

1 reference

18 December 2017

Annals of Emergency Medicine

published in

1 reference

18 December 2017

volume

20

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

795-801

1 reference

18 December 2017

Hypersensitivity to tetanus toxoid

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Successful treatment with antivenin of marked thrombocytopenia without significant coagulopathy following rattlesnake bite

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Antivenin and fasciotomy/debridement in the treatment of the severe rattlesnake bite

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Envenomation coagulopathy in wounds from pit vipers

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

A new method for quantitating hemorrhage induced by rattlesnake venoms: ability of polyvalent antivenom to neutralize hemorrhagic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Ability of polyvalent (Crotalidae) antivenom to neutralize local myonecrosis induced by Crotalus atrox venom

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Complications of Crotalidae antivenin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Perioperative Red Blood Cell Transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Hemolysis following platelet transfusions from ABO-incompatible donors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Febrile transfusion reaction: what blood component should be given next?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Leucocyte depleted blood: an appraisal of available techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

A serologic study of cytomegalovirus infections associated with blood transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Purification and large-scale preparation of antithrombin III.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Substitution of antithrombin III in shock and DIC: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980845-5

7 January 2021

10.1016/S0196-0644(05)80845-5

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017